Upload
darren-holmes
View
213
Download
0
Embed Size (px)
Citation preview
Alterations of Hormonal RegulationAlterations of Hormonal Regulation
Chapter 21Chapter 21
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
2Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Elevated or Depressed Elevated or Depressed Hormone LevelsHormone Levels
Failure of feedback systemsFailure of feedback systems Dysfunction of an endocrine glandDysfunction of an endocrine gland
Excessive/inadequate hormone productionExcessive/inadequate hormone production Altered hormone inactivation/degradationAltered hormone inactivation/degradation Ectopic hormone releaseEctopic hormone release
NonendocrineNonendocrine Autonomous production, no feedback mechanismsAutonomous production, no feedback mechanisms
3Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Target Cell FailureTarget Cell Failure Receptor-associated disordersReceptor-associated disorders
Decrease in number of receptorsDecrease in number of receptors Impaired receptor functionImpaired receptor function Presence of antibodies against specific receptorsPresence of antibodies against specific receptors Antibodies that mimic hormone actionAntibodies that mimic hormone action Unusual expression of receptor functionUnusual expression of receptor function
4Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Intracellular DisordersIntracellular Disorders
Inadequate synthesis of a second messengerInadequate synthesis of a second messenger Cyclic adenosine monophosphate (cAMP)Cyclic adenosine monophosphate (cAMP)
Failure of the target cell to produce anticipated Failure of the target cell to produce anticipated hormonal responsehormonal response Faulty response to hormone-receptor bindingFaulty response to hormone-receptor binding
• Failure to generate required second messenger Failure to generate required second messenger
• Abnormal response to the second messengerAbnormal response to the second messenger
5Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of the Alterations of the Hypothalamic-Pituitary SystemHypothalamic-Pituitary System
6Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diseases of the Posterior Diseases of the Posterior PituitaryPituitary
Syndrome of inappropriate antidiuretic hormone Syndrome of inappropriate antidiuretic hormone (SIADH) secretion(SIADH) secretion Ectopic secretion of ADH most common cause; also Ectopic secretion of ADH most common cause; also
common after surgerycommon after surgery For diagnosis, normal adrenal and thyroid function For diagnosis, normal adrenal and thyroid function
must existmust exist Clinical manifestations Clinical manifestations
• Related to enhanced renal water retentionRelated to enhanced renal water retention• HyponatremiaHyponatremia• HypoosmolarityHypoosmolarity
7Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diseases of the Posterior Diseases of the Posterior PituitaryPituitary
Diabetes insipidusDiabetes insipidus Insufficiency of ADHInsufficiency of ADH Polyuria and polydipsiaPolyuria and polydipsia Partial/total inability to concentrate the urinePartial/total inability to concentrate the urine NeurogenicNeurogenic
• Insufficient amounts of ADHInsufficient amounts of ADH
NephrogenicNephrogenic• Inadequate response to ADHInadequate response to ADH
8Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diseases of the Anterior PituitaryDiseases of the Anterior Pituitary Pituitary is vascular and therefore vulnerable Pituitary is vascular and therefore vulnerable
to ischemia and infarctionto ischemia and infarction HypopituitarismHypopituitarism
Pituitary infarctionPituitary infarction• Sheehan syndromeSheehan syndrome
• Hemorrhage Hemorrhage
• ShockShock
Others: head trauma, infections, and tumorsOthers: head trauma, infections, and tumors
9Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diseases of the Anterior PituitaryDiseases of the Anterior Pituitary HypopituitarismHypopituitarism
Panhypopituitarism (all hormones absent)Panhypopituitarism (all hormones absent)• ACTH deficiencyACTH deficiency
• TSH deficiencyTSH deficiency
• FSH and LH deficiencyFSH and LH deficiency
• GH deficiencyGH deficiency Glucose intoleranceGlucose intolerance
10Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diseases of the Anterior PituitaryDiseases of the Anterior Pituitary HyperpituitarismHyperpituitarism
Commonly due to a benign, slow-growing pituitary Commonly due to a benign, slow-growing pituitary adenomaadenoma
ManifestationsManifestations• Headache and fatigueHeadache and fatigue
• Visual changesVisual changes
• Hyposecretion of neighboring anterior pituitary hormonesHyposecretion of neighboring anterior pituitary hormones
11Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diseases of the Anterior PituitaryDiseases of the Anterior Pituitary Hypersecretion of growth hormone (GH)Hypersecretion of growth hormone (GH)
AcromegalyAcromegaly• Hypersecretion of GH during adulthoodHypersecretion of GH during adulthood
• Slowly progressiveSlowly progressive Mortality: cardiac hypertrophy, hypertension, Mortality: cardiac hypertrophy, hypertension,
atherosclerosis, type 2 diabetes mellitus lead to coronary atherosclerosis, type 2 diabetes mellitus lead to coronary artery diseaseartery disease
Malignancies common Malignancies common
GiantismGiantism• GH hypersecretion in children and adolescentsGH hypersecretion in children and adolescents
12Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Clinical Manifestations of Clinical Manifestations of AcromegalyAcromegaly
Connective tissue proliferationConnective tissue proliferation Enlarged tongue, interstitial edema, increase in the Enlarged tongue, interstitial edema, increase in the
size and function of sebaceous and sweat glands, size and function of sebaceous and sweat glands, coarse skin and body haircoarse skin and body hair
Bony proliferation Bony proliferation Large joint arthropathy Large joint arthropathy Periosteal vertebral growth Periosteal vertebral growth
• KyphosisKyphosis Enlargement of facial bones and hands and feet Enlargement of facial bones and hands and feet
• Protrusion of the lower jaw and forehead Protrusion of the lower jaw and forehead • Need for increasingly larger sizes of shoes, hats, rings, and Need for increasingly larger sizes of shoes, hats, rings, and
gloves gloves
13Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Hypersecretion of GHHypersecretion of GH
14Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diseases of the Anterior PituitaryDiseases of the Anterior Pituitary
Hypersecretion of prolactinHypersecretion of prolactin Caused by prolactinomasCaused by prolactinomas
• Most common hormonally active pituitary tumorMost common hormonally active pituitary tumor
• In females, increased levels of prolactin cause amenorrhea, In females, increased levels of prolactin cause amenorrhea, galactorrhea, hirsutism, and osteopeniagalactorrhea, hirsutism, and osteopenia
• In males, increased levels of prolactin cause hypogonadism, In males, increased levels of prolactin cause hypogonadism, erectile dysfunction, impaired libido, oligospermia, and erectile dysfunction, impaired libido, oligospermia, and diminished ejaculate volumediminished ejaculate volume
15Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Thyroid FunctionAlterations of Thyroid Function PrimaryPrimary
Dysfunction or disease of thyroid glandDysfunction or disease of thyroid gland• TH productionTH production
SecondarySecondary Alteration of pituitary TSH productionAlteration of pituitary TSH production
16Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alteration in Thyroid FunctionAlteration in Thyroid Function
PrimaryPrimary Hyperthyroidism, hypothyroidismHyperthyroidism, hypothyroidism ThyrotoxicosisThyrotoxicosis Graves' diseaseGraves' disease
• Pretibial myxedemaPretibial myxedema Hyperthyroidism resulting from nodular thyroid Hyperthyroidism resulting from nodular thyroid
diseasedisease• GoiterGoiter
Thyrotoxic crisisThyrotoxic crisis
17Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Thyrotoxicosis (Graves' Disease)Thyrotoxicosis (Graves' Disease)
18Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Thyroid FunctionAlterations of Thyroid Function HypothyroidismHypothyroidism
Primary hypothyroidismPrimary hypothyroidism• Subacute thyroiditisSubacute thyroiditis• Autoimmune thyroiditis (Hashimoto disease)Autoimmune thyroiditis (Hashimoto disease)• Painless thyroiditisPainless thyroiditis• Postpartum thyroiditisPostpartum thyroiditis• Myxedema comaMyxedema coma
Congenital hypothyroidismCongenital hypothyroidism Thyroid carcinomaThyroid carcinoma
19Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
HypothyroidismHypothyroidism
20Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Parathyroid Alterations of Parathyroid FunctionFunction
HyperparathyroidismHyperparathyroidism Primary hyperparathyroidismPrimary hyperparathyroidism
• Excess secretion of PTH from one or more parathyroid Excess secretion of PTH from one or more parathyroid glandsglands
• 85% caused by parathyroid adenomas85% caused by parathyroid adenomas
Secondary hyperparathyroidismSecondary hyperparathyroidism• Increase in PTH secondary to a chronic diseaseIncrease in PTH secondary to a chronic disease
Renal failureRenal failure Dietary deficiency of vitamin D, calciumDietary deficiency of vitamin D, calcium
21Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Parathyroid Alterations of Parathyroid FunctionFunction
HyperparathyroidismHyperparathyroidism HypercalciuriaHypercalciuria Alkaline urineAlkaline urine HyperphosphaturiaHyperphosphaturia
• Predisposes to the formation of calcium stones Predisposes to the formation of calcium stones
22Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Parathyroid Alterations of Parathyroid FunctionFunction
HypoparathyroidismHypoparathyroidism Abnormally low PTH levelsAbnormally low PTH levels
• Depressed serum calcium level Depressed serum calcium level
• Increased serum phosphate levelIncreased serum phosphate level
Usually caused by parathyroid damage in thyroid Usually caused by parathyroid damage in thyroid surgerysurgery
23Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Parathyroid Alterations of Parathyroid FunctionFunction
Hypoparathyroidism clinical signsHypoparathyroidism clinical signs Hypocalcemia Hypocalcemia
• Lowering of the threshold for nerve and muscle Lowering of the threshold for nerve and muscle excitation excitation
• Muscle spasms; hyperreflexia; tonic-clonic convulsions; Muscle spasms; hyperreflexia; tonic-clonic convulsions; laryngeal spasms; death from asphyxiation laryngeal spasms; death from asphyxiation
Phosphate retentionPhosphate retention
24Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diabetes MellitusDiabetes Mellitus Type 1Type 1 Type 2Type 2 Gestational diabetesGestational diabetes Glucose intoleranceGlucose intolerance
Fasting, 2 hour post glucose load, AFasting, 2 hour post glucose load, A11CC
Other typesOther types
25Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Type 1 Diabetes MellitusType 1 Diabetes Mellitus Demonstrates pancreatic atrophy and loss of Demonstrates pancreatic atrophy and loss of
beta cellsbeta cells Macrophages, T and B lymphocytes, and Macrophages, T and B lymphocytes, and
natural killer cells are presentnatural killer cells are present Two typesTwo types
Immune Immune NonimmuneNonimmune
26Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Type 1 Diabetes MellitusType 1 Diabetes Mellitus
Genetic susceptibilityGenetic susceptibility Environmental factorsEnvironmental factors Immunologically mediated destruction of beta Immunologically mediated destruction of beta
cellscells
27Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Type 1 Diabetes MellitusType 1 Diabetes Mellitus
Clinical manifestationsClinical manifestations HyperglycemiaHyperglycemia
• 80% to 90% of the function of the insulin-secreting beta cells 80% to 90% of the function of the insulin-secreting beta cells in the islet of Langerhans is lost in the islet of Langerhans is lost
Polydipsia, polyuria, polyphagia, weight loss, and Polydipsia, polyuria, polyphagia, weight loss, and fatiguefatigue
28Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Dysfunction of the PancreasDysfunction of the Pancreas Type 2 diabetes mellitusType 2 diabetes mellitus
Affects adults and childrenAffects adults and children Genetic environmental interactionGenetic environmental interaction Metabolic syndromeMetabolic syndrome TreatmentTreatment
• Exercise, treatment of obesity, medicationExercise, treatment of obesity, medication Clinical manifestationsClinical manifestations
• Recurrent infections, vision problems, neuropathyRecurrent infections, vision problems, neuropathy
29Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diabetes MellitusDiabetes Mellitus Maturity onset diabetes of youth (MODY)Maturity onset diabetes of youth (MODY) Gestational diabetesGestational diabetes
30Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Acute Complications of Acute Complications of Diabetes MellitusDiabetes Mellitus
HypoglycemiaHypoglycemia Diabetic ketoacidosisDiabetic ketoacidosis
Usually associated with Type 1Usually associated with Type 1 Illness, trauma, surgery, emotionsIllness, trauma, surgery, emotions Total body (not serum) potassium deficiencyTotal body (not serum) potassium deficiency Cerebral edema, especially in childrenCerebral edema, especially in children
31Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Acute Complications of Acute Complications of Diabetes MellitusDiabetes Mellitus
Hyperosmolar hyperglycemic nonketotic Hyperosmolar hyperglycemic nonketotic syndrome (HHNKS)syndrome (HHNKS) Usually associated with Type 2Usually associated with Type 2 Higher glucoseHigher glucose Less ketosisLess ketosis Severe dehydration and potassium deficitSevere dehydration and potassium deficit
32Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Acute Complications of Acute Complications of Diabetes MellitusDiabetes Mellitus
Somogyi effectSomogyi effect Usually associated with Type 1Usually associated with Type 1 Hypoglycemia with rebound hyperglycemiaHypoglycemia with rebound hyperglycemia Not as common as once thoughtNot as common as once thought
Dawn phenomenonDawn phenomenon Early morning glucose elevation without nocturnal Early morning glucose elevation without nocturnal
hypoglycemiahypoglycemia Related to nocturnal growth hormone elevationRelated to nocturnal growth hormone elevation
33Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Chronic Complications ofChronic Complications ofDiabetes MellitusDiabetes Mellitus
Hyperglycemia and nonenzymatic glycosylationHyperglycemia and nonenzymatic glycosylation Hyperglycemia and the polyol pathwayHyperglycemia and the polyol pathway
Sorbitol and fructose increase intracellular osmotic Sorbitol and fructose increase intracellular osmotic pressure (attracts water, leading to cell injury)pressure (attracts water, leading to cell injury)
Evident in the eye lens, nerves, RBCsEvident in the eye lens, nerves, RBCs Protein kinase CProtein kinase C
• Enzyme inappropriately activated by hyperglycemiaEnzyme inappropriately activated by hyperglycemia
Microvascular diseaseMicrovascular disease RetinopathyRetinopathy Diabetic nephropathyDiabetic nephropathy
34Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diabetic NephropathyDiabetic Nephropathy
35Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Complications of Diabetes MellitusComplications of Diabetes Mellitus Macrovascular diseaseMacrovascular disease
Coronary artery diseaseCoronary artery disease• Most common cause of death in persons with type 2Most common cause of death in persons with type 2
• Prevalence increases with duration of diseasePrevalence increases with duration of disease
StrokeStroke Peripheral arterial diseasePeripheral arterial disease
Diabetic neuropathiesDiabetic neuropathies InfectionInfection
36Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Diabetic NeuropathyDiabetic Neuropathy
37Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Adrenal FunctionAlterations of Adrenal Function Disorders of the adrenal cortexDisorders of the adrenal cortex
Cushing diseaseCushing disease• Excessive anterior pituitary secretion of ACTHExcessive anterior pituitary secretion of ACTH
Cushing syndromeCushing syndrome• Excessive level of cortisol, regardless of causeExcessive level of cortisol, regardless of cause
38Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Cushing DiseaseCushing Disease
39Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Adrenal FunctionAlterations of Adrenal Function Disorders of the adrenal cortexDisorders of the adrenal cortex
HyperaldosteronismHyperaldosteronism• Primary hyperaldosteronism (Conn disease)Primary hyperaldosteronism (Conn disease)
• Secondary hyperaldosteronismSecondary hyperaldosteronism
40Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Primary HyperaldosteronismPrimary Hyperaldosteronism
41Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Adrenal FunctionAlterations of Adrenal Function Disorders of the adrenal cortexDisorders of the adrenal cortex
Adrenocortical hypofunctionAdrenocortical hypofunction• Primary adrenal insufficiency (Addison disease)Primary adrenal insufficiency (Addison disease)
Idiopathic Addison diseaseIdiopathic Addison disease
• Secondary hypocortisolismSecondary hypocortisolism
42Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Adrenal FunctionAlterations of Adrenal Function Disorders of the adrenal cortexDisorders of the adrenal cortex
Hypersecretion of adrenal androgens and Hypersecretion of adrenal androgens and estrogensestrogens• FeminizationFeminization
• VirilizationVirilization
43Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
VirilizationVirilization
44Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Alterations of Adrenal FunctionAlterations of Adrenal Function Disorders of the adrenal medullaDisorders of the adrenal medulla
Adrenal medulla hyperfunctionAdrenal medulla hyperfunction• Caused by tumors derived from the chromaffin cells of Caused by tumors derived from the chromaffin cells of
the adrenal medullathe adrenal medulla PheochromocytomasPheochromocytomas
• Secrete catecholamines on a continuous or episodic Secrete catecholamines on a continuous or episodic basisbasis
45Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
PheochromocytomaPheochromocytoma